secwatch.observer — SEC 8-K summary
======================================

Issuer:     NexImmune, Inc. (—)
CIK:        0001538210
Form:       8-K
Filed at:   2023-04-26T23:59:59+00:00
Accession:  0001193125-23-118539
Event type: regulatory
Sentiment:  negative
Materiality: 0.45
Item codes: 3.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

NexImmune receives Nasdaq extension to Oct 23, 2023; stock moves to Capital Market
--------------------------------------------------------------------------------

- Nasdaq granted 180-day extension until Oct 23, 2023 to regain $1 minimum bid price compliance.
- Effective Apr 26, 2023, NexImmune common stock listing transferred to Nasdaq Capital Market.
- Company may consider reverse stock split to regain compliance; risk of delisting remains.
- Original non-compliance notice received Oct 25, 2022; grace period expired Apr 24, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1538210/000119312523118539/0001193125-23-118539-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1538210/000119312523118539/d493965d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-118539

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer